Latest filing published 12 Mar 2020 for BAILLIE GIFFORD UK GROWTH TRUST (BGUK), €28k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +70.0%Entry £1.37 · Close at T+365 £2.32
- +3.1%Entry £1.77 · Close at T+365 £1.82
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Scott Cochrane: trading record in brief
Scott Cochrane discloses dealings in Baillie Gifford UK Growth Trust (Bguk) to RNS (LSE). In total, 2 filings cover trades dated from 12 August 2019 to 12 March 2020.
Every open-market trade on record is a purchase: 2 purchases worth €50k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2020 alone, the filings show 1 purchase and no sales.
The newest entry dates from 12 March 2020: an open-market purchase of €28k, in Baillie Gifford UK Growth Trust (Bguk). This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Scott Cochrane
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,730 shares@ £1.4861100.0% of flowLONDON STOCK EXCHANGE, (XLON)ISIN GB0007913485FCA-NSM:LSE20200312153819_3525119_20200331164956916_13465Canonical exit: 10 Jun 2020 (T+90)
- 11,173 shares@ £1.7943.2% of flowLONDON STOCK EXCHANGE, (XLON)ISIN GB0007913485FCA-NSM:LSE20190812101124_14185143_20200326185058004_28613Canonical exit: 10 Nov 2019 (T+90)
2 of 2 declarations